Evidence map›Paper›PMID 42530667›Full record

ArticleInnere Medizin (Heidelberg, Germany)2026

[From sudden hearing loss to an inflammatory systemic disease].

Laura Hasler, Ariana Gaspert, Tobias Kleinjung, Mike Oliver Becker

Abstract readCase ReportsEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Innere Medizin (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Laura HaslerCurana Medizin AG, Zürich, Schweiz. laurahasler@outlook.com.
Ariana GaspertInstitut für Pathologie und Molekularpathologie, Universitätsspital Zürich, Zürich, Schweiz.
Tobias KleinjungKlinik für Ohren‑, Nasen‑, Hals- und Gesichtschirurgie, Universitätsspital Zürich, Zürich, Schweiz.
Mike Oliver BeckerKlinik für Rheumatologie, Universitätsspital Zürich, Zürich, Schweiz.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides are a group of rare autoimmune disorders characterized by necrotizing inflammation of small- to medium-sized blood vessels. They typically involve the upper and lower respiratory tracts and frequently the kidneys. However, they may also present with otologic manifestations, which can occasionally occur as an early or even the sole clinical symptom. The following case report outlines the course of the disease in a patient in whom bilateral hearing loss ultimately emerged as the leading manifestation of ANCA-associated vasculitis.

Indexed as

Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisGlomerulonephritisHearing Loss, BilateralHearing Loss, SuddenDiagnosis, DifferentialFemaleGranulomatosis with PolyangiitisHumansKidneyMaleANCA-associated vasculitisGlomerulonephritisGranulomatosis with polyangiitisKidney biopsyRituximab

Identifiers

PMID42530667
PMCPMC13529849

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.